Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Reprocell
AddedFeb 15, 2024
UpdatedJun 28, 2026
Reprocell

Reprocell

Public

Yokohama-based ReproCell Inc. pioneers in iPS and ES technology for drug discovery and organ transplantation.

HQ
Yokohama, Kanagawa Prefecture, JP
Founded
2003
Overview
Compare
Employees
Website

Founded in Yokohama, Japan, ReproCell Inc. is dedicated to advancing drug discovery and organ transplantation through the use of Induced Pluripotent Stem Cell (iPS) and Embryonic Stem Cell (ES) technologies. The company offers a range of services and products, including preclinical and clinical research solutions, stem cell and gene editing services, precision medicine, and human tissue samples. Their market focus spans from academic research institutions to pharmaceutical companies looking to innovate in the fields of regenerative medicine and personalized healthcare.

ReproCell has attracted notable investors and affiliations within the biotech and pharmaceutical sectors, contributing to its reputation as a leader in stem cell technology. Key achievements include the development of advanced stem cell products and services that support mesenchymal stem cell (MSC) research and 3D cell culture. The company's impact is significant in both the scientific community and the broader medical field, driving forward the capabilities of precision medicine and offering new avenues for therapeutic interventions.

Reprocell - Similar Companies

Celularity logo

Celularity

celularity.com

International Stem Cell logo

International Stem Cell

LaCell logo

LaCell

Cell Reprogramming & Therapeutics logo

Cell Reprogramming & Therapeutics

Stemcyte logo

Stemcyte

stemcyte.com

StemBioSys logo

StemBioSys

stembiosys.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

RoosterBio logo

RoosterBio

Progenitor Life Sciences logo

Progenitor Life Sciences

MitoStem logo

MitoStem

Cellino logo

Cellino

cellinobio.com

Stemtech logo

Stemtech

stemtech.com

ViaCyte logo

ViaCyte

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

Personalized Stem Cells logo

Personalized Stem Cells

Reprocell - Quick Facts

Who are Reprocell's competitors?

Companies similar to Reprocell include Celularity, International Stem Cell, LaCell and Cell Reprogramming & Therapeutics.

When was Reprocell founded?

Reprocell was founded in 2003.

Where is Reprocell's headquarters located?

Reprocell's headquarters is located in Yokohama, Kanagawa Prefecture, JP.

How many employees does Reprocell have?

Reprocell has 92 employees as of Feb 6, 2024.

Reprocell - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Services
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Drug Discovery
  • Stem Cells
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified